Universal Roe from 2010 to 2024

UHS Stock  USD 197.61  0.09  0.05%   
Universal Health ROE yearly trend continues to be comparatively stable with very little volatility. ROE will likely drop to 0.10 in 2024. From the period from 2010 to 2024, Universal Health ROE quarterly data regression had r-value of (0.58) and coefficient of variation of  14.54. View All Fundamentals
 
ROE  
First Reported
2010-12-31
Previous Quarter
0.1167336
Current Value
0.1
Quarterly Volatility
0.02099886
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Universal Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Universal Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 596.4 M, Interest Expense of 217.6 M or Total Revenue of 15 B, as well as many indicators such as Price To Sales Ratio of 0.57, Dividend Yield of 0.0065 or PTB Ratio of 1.55. Universal financial statements analysis is a perfect complement when working with Universal Health Valuation or Volatility modules.
  
Check out the analysis of Universal Health Correlation against competitors.

Latest Universal Health's Roe Growth Pattern

Below is the plot of the Roe of Universal Health Services over the last few years. It is Universal Health's ROE historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Universal Health's overall financial position and show how it may be relating to other accounts over time.
Roe10 Years Trend
Slightly volatile
   Roe   
       Timeline  

Universal Roe Regression Statistics

Arithmetic Mean0.14
Geometric Mean0.14
Coefficient Of Variation14.54
Mean Deviation0.02
Median0.15
Standard Deviation0.02
Sample Variance0.0004
Range0.0734
R-Value(0.58)
Mean Square Error0.0003
R-Squared0.34
Significance0.02
Slope(0)
Total Sum of Squares0.01

Universal Roe History

2024 0.1
2023 0.12
2022 0.11
2018 0.14
2014 0.15
2012 0.16
2011 0.17

About Universal Health Financial Statements

Universal Health shareholders use historical fundamental indicators, such as Roe, to determine how well the company is positioned to perform in the future. Although Universal Health investors may analyze each financial statement separately, they are all interrelated. The changes in Universal Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on Universal Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
ROE 0.12  0.10 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Universal Stock Analysis

When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.